↓ Read PDF
01 · ABSTRACT

Abstract

Introduction: The TBICheckTM Rapid test is an immunochromatographic rapid test capable of assisting in the triage of patients with mild Traumatic Brain Injury suspected of brain lesions. It quantitatively determines heart-type Fatty Acid Binding Protein (H-FABP) levels in whole blood, serum, or plasma. The aim of the present study was to evaluate its technical performance and test it in two different cohorts of mTBI patients as a potential diagnostic tool for detecting brain lesions in patients with mTBI.

Material and methods: Description of the assay: Linearity and low limit of quantification of TBICheckTM lateral flow assay were determined using serial dilution of standardized samples. Results were read using the TBICheckTM Reader, a mobile photometric immunoassay analyzer based on reflectance measurements to capture the optical density. Obtained results were compared to classical ELISA assays, Meso Scale Diagnostics. Patient cohorts: Two different cohorts of adult mTBI patients were included: a retrospective one including 82 patients and a prospective one including 65 patients. Values of H-FABP area under the curve, specificity, sensitivity were calculated.

Results: The H-FABP dose response fitted a linear regression within the range of 0.5-25 ng/mL. LLOQ in blood was 0.5 ng/mL. High Spearman correlation was found (ρ=0.933, p<0.001) when MSD ELISA and TBICheckTM concentrations were compared.

In the retrospective cohort, when the clinical sensitivity was set at 100%, a specificity value of 32.9% was obtained. In the prospective cohort, the SP value raised to 66.1% with 100% SE, meaning that 6 out of 10 patients might be discharged on the basis of their serum H-FABP concentration at hospital admission.

Conclusions: The quantification of H-FABP by using the TBICheckTM Rapid test on adult mTBI patients may allow to rule out the need of a CT-scan reducing the radiation exposure and avoiding the long waiting times in emergency units. It may lead to savings in hospital resources and assists medical doctors to provide the most appropriate treatment to the patients.

 

↓ Read PDF
02 · PUBLICATION RECORD

Article details

JournalMedical Research Archives
IssueVol 11 No 9 (2023): September Issue, Vol.11, Issue 9
SectionResearch Articles
Published04 October 2023
DOI10.18103/mra.v11i9.4297
ISSN2375-1924
03 · RIGHTS & REUSE

Rights & reuse

This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.

Authors & affiliations

AL

Azurmendi L.

Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland

CN

Cancelliere N.

Intensive Care Unit, Hospital Universitario La Paz, Madrid, Spain

SL

Sempere L.

Neurovascular Research Laboratory, Instituto de Biomedicina de Sevilla-IBiS, Sevilla, Spain

DA

Diez Naz A.

Emergency Department, Virgen del Rocio Hospital, Seville, Spain

CN

Cancelliere N.

Intensive Care Unit, Hospital Universitario La Paz, Madrid, Spain

MB

Menendez B.

Department of Neurosurgery, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain

GR

Garcia Armengol R.

Department of Neurosurgery, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain

PM

Perea M.

Servicio de Urgencias, Hospital Clínic i Provincial, Universitat de Barcelona

MJ

Montaner j.

Department of Neurology, Hospital Universitario Virgen Macarena, Sevilla, Spain; Neurovascular Research Laboratory, Instituto de Biomedicina de Sevilla-IBiS, Sevilla, Spain

SJ

Sanchez J-C

Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Medical Research Archives

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Start your submission  ↗